Tetrazine Synthesis via Ag-Mediated Liebeskind-Srogl Cross-Coupling

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for introducing tetrazine groups to molecules are limited by the need for harsh reaction conditions, high-nitrogen byproducts, and incompatibility with certain functional groups, which restricts the scalability and scope of bioorthogonal chemistry applications.

Innovation Solution

The development of a method involving cross-coupling of arylboronic acids with thio-substituted tetrazine reagents under mild conditions, using Ag-mediated Liebeskind-Srogl reactions, and a one-pot synthesis of 3-thiomethyltetrazines from carboxylic esters, allowing for the introduction of linker-free tetrazine functionality and broad functional group tolerance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If carboxylic esters are used as handles for introducing tetrazine groups via amide bond forming reactions, then tetrazine groups can be introduced to molecules, but large and hydrophobic linkers are required which negatively impact the physiochemical properties of the conjugate

Engineering Contradiction:
Improveease of introducing tetrazine groupsVSAvoidphysiochemical properties of conjugate
Core Design Contradiction:
Ease of manufactureVSStability of the object's composition

Solution Approach 1:

The invention extracts and eliminates the problematic linker component from the conjugate structure. By developing methods for direct attachment of tetrazine fragments to target molecules without requiring linker intermediates, the patent removes the source of hydrophobicity and bulk that negatively impact physiochemical properties, while still achieving the goal of introducing tetrazine groups.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention introduces new intermediary reagents and reaction conditions that enable direct coupling. Specifically, the patent employs activated esters, fluorogenic reagents, and optimized coupling conditions that allow tetrazine fragments to attach directly to target molecules without traditional linkers, thereby maintaining physiochemical properties while achieving efficient conjugation.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If many approaches to tetrazine synthesis are used, then tetrazine groups can be synthesized, but high-nitrogen byproducts are produced and harsh reaction conditions are required which limit scalability and scope

Engineering Contradiction:
Improvetetrazine synthesis capabilityVSAvoidhigh-nitrogen byproducts and harsh conditions
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The invention changes the reaction parameters and conditions to achieve milder synthesis. The patent employs optimized temperature controls, pH adjustments, and alternative reagent systems that reduce the formation of high-nitrogen byproducts while maintaining high tetrazine synthesis efficiency. These parameter changes enable scalability and broaden the scope of applicable substrates.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention converts potentially harmful byproducts into beneficial outcomes. By developing selective synthesis pathways that minimize high-nitrogen byproduct formation and employing purification strategies that selectively recover desired tetrazine products, the patent transforms what would be waste material into opportunities for improved process efficiency and reduced environmental impact.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

3Ease of manufacture

If tetrazines are used in metal catalyzed cross-couplings, then tetrazine fragments can be introduced, but the deactivating amino substituent attenuates utility in bioorthogonal chemistry and tetrazines are sensitive to basic conditions

Engineering Contradiction:
Improvetetrazine fragment introductionVSAvoidutility in bioorthogonal chemistry
Core Design Contradiction:
Ease of manufactureVSAdaptability or versatility

Solution Approach 1:

The invention applies local quality modifications to the tetrazine structure. By strategically placing protecting groups, activating moieties, or structural modifications at specific positions on the tetrazine ring, the patent maintains the essential bioorthogonal reactivity at key locations while modifying other regions to reduce sensitivity to basic conditions and eliminate deactivating effects.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention creates composite tetrazine structures that combine multiple functional elements. By synthesizing tetrazines with integrated protecting groups, solubility-enhancing moieties, or structurally modified rings that combine the benefits of different chemical features, the patent achieves both ease of manufacture through cross-coupling and maintained versatility for bioorthogonal chemistry applications.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the safe and efficient introduction of tetrazine groups, improving the physiochemical properties of ligands and expanding the scope of bioorthogonal chemistry applications with higher yields and improved functional group compatibility.

Implementation Method 1

cross-coupling of arylboronic acids with thio-substituted tetrazine reagents under mild conditions, using Ag-mediated Liebeskind-Srogl reactions

Methodology Applied
Scientific EffectCross-coupling reaction: Chemical Bonding

Implementation Method 2

one-pot synthesis of 3-thiomethyltetrazines from carboxylic esters

Methodology Applied
Scientific EffectChemical transformation: Chemical Bonding

Data Source

PatentUS11767302B2Reagents and methods for tetrazine synthesis
Publication Date: 2023.09.26 UNIVERSITY OF DELAWARE
  • US11767302B2 patent drawing
  • US11767302B2 patent drawing
  • US11767302B2 patent drawing

AI summary

Disclosed herein are mono- and di-substituted tetrazines and methods of their preparation and converting an oxetanyl ester to a thio-substituted tetrazine, which is then converted to a mono-substituted tetrazine, a di-substituted tetrazine, or a vinylether disubstituted tetrazine.